0000000000625528

AUTHOR

K Martin

showing 2 related works from this author

Technical design report for the $\overline{{\rm{P}}}\mathrm{ANDA}$ Barrel DIRC detector

2019

The $\overline{{\rm{P}}}\mathrm{ANDA}$ (anti-Proton ANnihiliation at DArmstadt) experiment will be one of the four flagship experiments at the new international accelerator complex FAIR (Facility for Antiproton and Ion Research) in Darmstadt, Germany. $\overline{{\rm{P}}}\mathrm{ANDA}$ will address fundamental questions of hadron physics and quantum chromodynamics using high-intensity cooled antiproton beams with momenta between 1.5 and 15 GeV/c and a design luminosity of up to 2 × 1032 cm−2 s−1. Excellent particle identification (PID) is crucial to the success of the $\overline{{\rm{P}}}\mathrm{ANDA}$ physics program. Hadronic PID in the barrel region of the target spectrometer will be per…

PhysicsNuclear and High Energy PhysicsRange (particle radiation)Large Hadron ColliderPhysics::Instrumentation and Detectors010308 nuclear & particles physicsHadronDetectorBarrel (horology)7. Clean energy01 natural sciencesRing-imaging Cherenkov detectorParticle identificationCharged particleNuclear physics0103 physical sciencesHigh Energy Physics::Experimentddc:530010306 general physicsNuclear Experiment
researchProduct

Molecular biomarkers in glaucoma

2013

The seventh annual ARVO/Pfizer Ophthalmic Research Institute conference was held Friday and Saturday, April 29 and 30, 2011, at the Fort Lauderdale Hyatt Regency Pier 66, Fort Lauderdale, Florida. The conference, funded by The ARVO Foundation for Eye Research through a grant from Pfizer Ophthalmics, provided an opportunity to gather experts from within and outside ophthalmology to determine the state of knowledge pertaining to molecular biomarkers associated with glaucoma, as well as the methods to identify and validate them to predict (a) those who would be susceptible to development of glaucoma; (b) markers that will enable prediction of glaucoma progression; and (c) markers that will pre…

Genetic MarkersProteomicsmedicine.medical_specialtygenetic structuresGlaucomaHuman healthCellular and Molecular NeuroscienceOphthalmologyMedicineHumansBiomarkers; Genetic Markers; Genomics; Glaucoma; Humans; Metabolome; Proteomics; Ophthalmology; Sensory Systems; Cellular and Molecular Neuroscience; Medicine (all)Biomarker discoveryBlindnessbusiness.industryMedicine (all)GlaucomaArticlesGenomicsmedicine.diseaseMolecular biomarkerseye diseasesBench to bedsideSensory SystemsOphthalmologyMetabolomeOptometrysense organsbusinessBiomarkers
researchProduct